← Leaderboards
Natalya Y Rapoport
University Of Utah
$2,983,111
Attributed
$2,983,111
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $351K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,983,111 · 3
By mechanism
R01$2,632,131 · 2
R56$350,980 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsMicellesExtravasationCopolymerEmulsionsEnhancersDensityBlood CapillariesAcousticsDrug CarriersBaseDesignAnimalsEncapsulatedCancer PatientAdverse EffectsBlood CirculationContrast MediaDiagnosticCell MembraneDialysis ProcedureDoxorubicinChemotherapyElements
Grant awards (10)
Acoustically Activated Micellar Drug Delivery$335,239
R01 · FY2010 · EB · contact PI
Acoustically Activated Micellar Drug Delivery$338,625
R01 · FY2009 · EB · contact PI
Acoustically Activated Micellar Drug Delivery$338,251
R01 · FY2008 · EB · contact PI
Acoustically Activated Micellar Drug Delivery$350,980
R56 · FY2007 · EB · contact PI
Acoustically Activated Micellar Drug Delivery$281,182
R01 · FY2005 · EB
Acoustically Activated Micellar Drug Delivery$281,868
R01 · FY2004 · EB
Acoustically Activated Micellar Drug Delivery$282,526
R01 · FY2003 · EB
Acoustically Activated Micellar Drug Delivery$291,878
R01 · FY2002 · EB
ACOUSTICALLY ACTIVATED MICELLAR DRUG DELIVERY$244,848
R01 · FY2001 · CA
ACOUSTICALLY ACTIVATED MICELLAR DRUG DELIVERY$237,714
R01 · FY2000 · CA